Robert Gross

Dr. Robert Gross is an advocate for innovation in the field of neurology, particularly in the development of novel gene and computational approaches to address complex neurological disorders such as epilepsy and Parkinson's disease. As a Professor at the Georgia Institute of Technology, he is dedicated to advancing the understanding and treatment of these conditions through cutting-edge research and technology. Dr. Gross leads the Translational Neuroengineering Research Lab, where his team focuses on neuromodulation techniques. These include the use of multielectrode arrays, closed-loop control theory, and optogenetics to modulate neural activity. His research aims to develop therapeutic strategies that can restore normal function in the brain, offering hope for patients with degenerative and injury-related conditions. In addition to his work on neuromodulation, Dr. Gross is deeply involved in exploring neurorestoration through gene and cell-therapy based approaches. His research is pioneering in the development of novel gene therapy vectors designed to target proteins that regulate axon outgrowth, a critical aspect of neurorestoration. This work holds significant promise for advancing treatments for a variety of neurological disorders. Dr. Gross's contributions to the field extend beyond his laboratory. He is actively engaged in the scientific community, collaborating with fellow researchers and sharing his findings through publications and conferences. His commitment to innovation and excellence in research has made him a respected figure in the field of neurology. Through his work, Dr. Gross continues to push the boundaries of what is possible in the treatment of neurological disorders, striving to improve the quality of life for patients worldwide. His dedication to research and education reflects his passion for making a meaningful impact in the field of neurology.